Â鶹ÊÓƵapp

Dr. Vamsidhar Velcheti discusses a promising targeted therapy based on the results of a clinical trial.

Dr. Joshua K. Sabari discusses a new drug for people with a rare form of non-small cell lung cancer.

The studies’ span speaks to NYU Langone’s strong ability to lead multicenter trials in rheumatology.

Faced with countless unknowns, researchers hunt for therapeutics and vaccines to foil COVID-19.

Researchers investigate clues to help diagnose and treat Parkinson’s disease before symptom onset.

Experts use clinical expertise and basic science research to diagnose a rare autoimmune disorder.

Trial examines hydroxychloroquine’s ability to ward off infections in people exposed to the virus.

Examining resected tumors reveals a lung microbiota signature associated with a poor prognosis.

The host–microbe relationship plays a key role in this stubborn infection.

Dozens of trials explore a wide variety of drug strategies and tumor types.